Literature DB >> 10471596

Validity of markers of dilution in small volume lung lavage.

P A Dargaville1, M South, P Vervaart, P N McDougall.   

Abstract

Definitive analysis of solute concentrations in lung lavage fluid involves the use of a marker of dilution to correct for variable recovery of epithelial lining fluid (ELF), but the question of the most appropriate dilutional marker remains unresolved. In lavage fluid collected from infants with lung disease and healthy control subjects, we examined ELF concentration of protein, albumin, sphingomyelin (SM), and IgA secretory component (SC), and critically appraised the relative validity of SC and urea as dilutional markers in the context of lung infection and lung injury. Protein, albumin, and SM were found not to be valid dilutional markers, as their ELF concentration varied significantly between the diseased, recovering, and normal lung. Differences in concentration were noted in both tracheal aspirate samples (TA, 4 x 0.5 ml) and nonbronchoscopic bronchoalveolar lavage fluid (NB-BAL, 3 x 1 ml/kg), but were not uniform (e.g., TA-disease versus control: albumin 2.8 versus 0.68 mg/ml, SM 45 versus 16 microgram/ml, both p < 0.05; NB-BAL-disease versus recovery: protein 8.1 versus 4.8 mg/ml, albumin 2.9 versus 1. 4 mg/ml, both p < 0.05). Overall, SC concentrations in ELF were not different between the diseased and normal lung, but in the NB-BAL samples, significantly higher SC concentration was noted in viral bronchiolitis and pneumonia than in noninfective lung diseases. No clear evidence of additional influx of urea into lavage fluid in association with epithelial disruption was found in the diseased lung. Comparative analysis of SC and urea revealed no difference in TA samples, but in NB-BAL specimens, urea best standardized the lavage concentration of surfactant indices to correspond to the degree of lung dysfunction as indicated by oxygenation index. We conclude that SC and urea, but not protein, albumin, or SM, are valid dilutional markers with which to estimate ELF recovery during small volume lung lavage. Urea appears a more appropriate choice in return fluid derived from the distal tracheobronchial tree, and SC should not be used in the context of lung infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471596     DOI: 10.1164/ajrccm.160.3.9811049

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  27 in total

1.  Comparison of the pharmacodynamics of biapenem in bronchial epithelial lining fluid in healthy volunteers given half-hour and three-hour intravenous infusions.

Authors:  Eiki Kikuchi; Junko Kikuchi; Yasuyuki Nasuhara; Satoshi Oizumi; Akitoshi Ishizaka; Masaharu Nishimura
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

2.  HFOV in premature neonates: effects on pulmonary mechanics and epithelial lining fluid cytokines. A randomized controlled trial.

Authors:  Giovanni Vento; Piero G Matassa; Franco Ameglio; Ettore Capoluongo; Enrico Zecca; Luca Tortorolo; Mara Martelli; Costantino Romagnoli
Journal:  Intensive Care Med       Date:  2005-02-17       Impact factor: 17.440

Review 3.  Interpretation of antibiotic concentration ratios measured in epithelial lining fluid.

Authors:  Sungmin Kiem; Jerome J Schentag
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

4.  Bronchopulmonary pharmacokinetics of (R)-salbutamol and (S)-salbutamol enantiomers in pulmonary epithelial lining fluid and lung tissue of horses.

Authors:  Glenn A Jacobson; Sharanne Raidal; Kate Robson; Christian K Narkowicz; David S Nichols; E Haydn Walters
Journal:  Br J Clin Pharmacol       Date:  2017-02-08       Impact factor: 4.335

5.  Quantification of amikacin in bronchial epithelial lining fluid in neonates.

Authors:  C Tayman; M N El-Attug; E Adams; A Van Schepdael; A Debeer; K Allegaert; A Smits
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

6.  Bronchoalveolar lavage fluid peptidomics suggests a possible matrix metalloproteinase-3 role in bronchopulmonary dysplasia.

Authors:  Giovanni Vento; Chiara Tirone; Paola Lulli; Ettore Capoluongo; Franco Ameglio; Simona Lozzi; Francesco Cota; Fabio Mosca; Costantino Romagnoli; Irene Messana; Massimo Castagnola; Rosanna Inzitari
Journal:  Intensive Care Med       Date:  2009-09-25       Impact factor: 17.440

7.  The Relationship Between Airway Antioxidant Levels, Alcohol Use Disorders, and Cigarette Smoking.

Authors:  Ellen L Burnham; Alicia McNally; Jeanette Gaydos; Lou Ann S Brown
Journal:  Alcohol Clin Exp Res       Date:  2016-09-14       Impact factor: 3.455

8.  Bacterial ventilator-associated pneumonia: bronchoalveolar lavage results are not influenced by dilution.

Authors:  Olivier Baldesi; Fabrice Michel; Christophe Guervilly; Nathalie Embriaco; Aliocha Granfond; Bernard La Scola; Henri Portugal; Laurent Papazian
Journal:  Intensive Care Med       Date:  2009-02-03       Impact factor: 17.440

9.  Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases.

Authors:  Eva Lorenz; Marianne S Muhlebach; Philippe A Tessier; Neil E Alexis; R Duncan Hite; Michael C Seeds; David B Peden; Wayne Meredith
Journal:  Respir Med       Date:  2007-12-27       Impact factor: 3.415

10.  DNA and inflammatory mediators in bronchoalveolar lavage fluid from children with acute inhalational injuries.

Authors:  Benny L Joyner; Samuel W Jones; Bruce A Cairns; Bradford D Harris; Andrea M Coverstone; Kathleen A Abode; Shiara M Ortiz-Pujols; Keith C Kocis; Terry L Noah
Journal:  J Burn Care Res       Date:  2013 May-Jun       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.